Home

Aarti Drugs Ltd EPS

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

EPS

₹ 16.56

Last updated on: Jan 24, 2025

Key Highlights

  • The Earning per Share of Aarti Drugs Ltd is ₹ 16.56 as of 24 Jan 25 .
  • The earning per share of Aarti Drugs Ltd changed from ₹ 5.18 to ₹ 3.83 over 6 quarters. This represents a CAGR of -18.23% .

Historical Earning per Share of Aarti Drugs Ltd

No data available

* All values are in

Company Fundamentals for Aarti Drugs Ltd

Market Cap

3,763 Cr

EPS

16.6

P/E Ratio (TTM)

24.7

P/B Ratio (TTM)

2.9

Day’s High

406.75

Day’s Low

395.05

DTE

0.5

ROE

11.9

52 Week High

634.9

52 Week Low

395.05

ROCE

12.8

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Jan 2025409.4
23 Jan 2025414.4
22 Jan 2025415.9
21 Jan 2025425
20 Jan 2025425.85
17 Jan 2025421.25
16 Jan 2025421.3
15 Jan 2025415.25
14 Jan 2025420.15
13 Jan 2025422.65

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Aarti Drugs Ltd

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

3,764

Asset Value

Value addition

1.8 X

1,321

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Aarti Drugs Ltd3763
Sun Pharmaceuticals Industries Ltd437135
Divis Laboratories Ltd153074
Cipla Ltd114019
Torrent Pharmaceuticals Ltd109914
Mankind Pharma Ltd103383

Historical Market Cap of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aarti Drugs Ltd News Hub

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Friday's closin

Read more

26 Aug 24

Aarti Drugs to consider buyback

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024. Powered

Read more

22 Aug 24

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billion Aarti G

Read more

22 Aug 24

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up to 6,65,00

Read more

26 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Aarti Drugs Ltd

What is the EPS of Aarti Drugs Ltd stock?

The Earnings Per Share (EPS) of Aarti Drugs Ltd is 16.56. An EPS is the amount of net income attributed to each share of a common stock.

How is Aarti Drugs Ltd EPS calculated?

The EPS of Aarti Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aarti Drugs Ltd report its EPS?

Aarti Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aarti Drugs Ltd EPS?

Factors that influence the EPS of Aarti Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aarti Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Aarti Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions